Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2022-3716

20
FAUCET Score

CVE-2022-3716 is a medium-severity cross-site scripting (XSS) vulnerability affecting SourceCodester Online Medicine Ordering System 1.0. An authenticated attacker can inject malicious scripts into the "First Name," "Middle Name," or "Last Name" fields within the /omos/admin/?page=user/list functionality. This remote vulnerability has a CVSS score of 5.4, indicating low impact on confidentiality and integrity, with no impact on availability. There is currently no public exploit code available, no evidence of active exploitation, and minimal community discussion or media coverage.

Impacted Technologies

VendorProductVersion(s)CPE
1.0CPE matchmatch criteria
cpe:2.3:a:oretnom23:online_medicine_ordering_system:1.0:*:*:*:*:*:*:*

CVSS Data

CVSS version used by this source: 3.1

3.5LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N

Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
UNCHANGED
Confidentiality Impact
NONE
Integrity Impact
LOW
Availability Impact
NONE
Exploitability Score
2.1
Impact Score
1.4
CvssVersion
3.1

Exploit Intelligence

EPSS Score
0.33%
Probability of exploitation in next 30 days
EPSS Percentile
25.2%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0033 is in the 36th percentile among its peer group of 15,239 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.0 Bluesky, 0.0 Mastodon, and 0.1 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.0 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

vuldb.com
Third Party Advisory